Poirot
Benjamin Poirot, Champagne Les Marais FR
Patent application number | Description | Published |
---|---|---|
20120231149 | Method for Treating Honey in Order to Obtain a Clear Liquid Honey - The present invention relates to a method for treating honey which is at least partially crystallized, with a view to obtaining a honey which can be stored for several months at ambient temperature while remaining liquid and transparent. The method is based on the separation and extraction of at least a part of the glucose crystals present in the honey. This extraction can be carried out by centrifugation or by ultrafiltration. This method excludes heating the honey at a high temperature for a long period of time, and therefore makes it possible to preserve all the properties thereof. | 09-13-2012 |
Bertrand Poirot, Villers Les Nancy FR
Patent application number | Description | Published |
---|---|---|
20100300446 | SYSTEMS AND METHODS FOR PROTECTING COMPONENTS OF A BREATHING ASSISTANCE SYSTEM - A breathing assistance system includes a gas delivery system that generates a gas flow, a fluid source (e.g., a humidifier system or supplemental gas supply) located downstream from the gas delivery system that humidifies the gas flow generated by the gas delivery system, a gas flow conduit system for communicating the gas flow from the gas delivery system, and a flow regulation device. The flow regulation device is physically moveable between (a) an operational position that allows the gas flow generated by the gas delivery system to flow downstream past the flow regulation device via the gas flow conduit system, and (b) a protection position that prevents gasses and liquids flowing upstream through the gas flow conduit system from reaching the gas delivery system, and instead directs such gasses and liquids through an exhaust opening in the gas flow conduit system. The flow regulation device automatically moves between the operational position and the protection position based at least on a gas pressure upstream of the flow regulation device. | 12-02-2010 |
20110011400 | WIRELESS, GAS FLOW-POWERED SENSOR SYSTEM FOR A BREATHING ASSISTANCE SYSTEM - A breathing assistance system for providing breathing assistance to a patient includes a gas delivery system configured to generate a gas flow, a patient interface configured to interface with the patient, a connection system connected between the gas delivery system and the patient interface and configured to communicate the gas flow to the patient interface for delivery to the patient, and a sensor system remote from the gas delivery system and connected to at least one of the patient interface and the connection system. The sensor system may include a sensor for measuring a parameter, one or more actuators, and a power supply based on a turbine configured to be driven by the gas flow and an electrical generator coupled to the turbine and configured to generate electricity. | 01-20-2011 |
Bertrand Poirot, Gasville Oiseme FR
Patent application number | Description | Published |
---|---|---|
20120321714 | SOLID PHARMACEUTICAL COMPOSITION CONTAINING 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA (C)CHROMEN-3-YL SULFAMATE AND POLYMORPHS THEREOF - The present invention relates to a solid pharmaceutical composition including the active principle 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. The present invention also relates to polymorphs of the 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate compound. | 12-20-2012 |
20140056977 | SOLID PHARMACEUTICAL COMPOSITION CONTAINING 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA (C)CHROMEN-3-YL SULFAMATE AND POLYMORPHS THEREOF - The present invention relates to a solid pharmaceutical composition including the active principle 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. The present invention also relates to polymorphs of the 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate compound. | 02-27-2014 |
Charlotte Poirot, Paris FR
Patent application number | Description | Published |
---|---|---|
20130155496 | GLASS PANEL HAVING SUN-SHIELDING PROPERTIES - The invention relates to solar-control glazing comprising a glass substrate and a solar-control thin-film multilayer, said thin-film multilayer incorporating a film selectively absorbing infrared radiation having a wavelength longer than 800 nm, said absorbing film consisting of a titanium oxide substituted with an element X chosen from Nb or Ta, the atomic percentage [X/Ti+X] lying between about 4% and about 9% and the thickness of said absorbing film lying between about 20 and about 200 nanometers. | 06-20-2013 |
Christophe Poirot, Moyenmoutier FR
Patent application number | Description | Published |
---|---|---|
20100030027 | INTRAORAL MEDICAL DEVICE - The present invention relates to an intraoral medical device comprising: • a mouth opener ( | 02-04-2010 |
Laurent Poirot, Paris FR
Patent application number | Description | Published |
---|---|---|
20130315884 | METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT T CELL FOR IMMUNOTHERAPY - Methods for developing engineered T-cells for immunotherapy that are both non-alloreactive and resistant to immunosuppressive drugs. The present invention relates to methods for modifying T-cells by inactivating both genes encoding target for an immunosuppressive agent and T-cell receptor, in particular genes encoding CD52 and TCR. This method involves the use of specific rare cutting endonucleases, in particular TALE-nucleases (TAL effector endonuclease) and polynucleotides encoding such polypeptides, to precisely target a selection of key genes in T-cells, which are available from donors or from culture of primary cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies for treating cancer and viral infections. | 11-28-2013 |
20150017136 | METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPY - The present invention relates to methods for developing engineered T-cells for immunotherapy that are non-alloreactive. The present invention relates to methods for modifying T-cells by inactivating both genes encoding T-cell receptor and an immune checkpoint gene to unleash the potential of the immune response. This method involves the use of specific rare cutting endonucleases, in particular TALE-nucleases (TAL effector endonuclease) and polynucleotides encoding such polypeptides, to precisely target a selection of key genes in T-cells, which are available from donors or from culture of primary cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies for treating cancer and viral infections. | 01-15-2015 |
20150203817 | USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR ALPHA DEFICIENT T CELLS - A method of expanding TCRalpha deficient T-cells by expressing pTalpha or functional variants thereof into said cells, thereby restoring a functional CD3 complex. This method is particularly useful to enhance the efficiency of immunotherapy using primary T-cells from donors. This method involves the use of pTalpha or functional variants thereof and polynucleotides encoding such polypeptides to expand TCRalpha deficient T-cells. Such engineered cells can be obtained by using specific rare-cutting endonuclease, preferably TALE-nucleases. The use of Chimeric Antigen Receptor (CAR), especially multi-chain CAR, in such engineered cells to target malignant or infected cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies for treating cancer and viral infections. | 07-23-2015 |
Marc Poirot, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20140274984 | ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA-OL - The present invention relates to acid addition salts of 5α-hydroxy-6β-[2-(1H-imidazol-4-yl)ethylamino]cholestan-3β-ol, to their preparation and to applications thereof. | 09-18-2014 |
20140309417 | PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES - The present invention relates to a process for the preparation of sterol derivatives comprising the reaction of an α-epoxy compound with an amine in an alcohol comprising 3 to 5 carbon atoms as a solvent. | 10-16-2014 |
Marc Poirot, L'Union FR
Patent application number | Description | Published |
---|---|---|
20110275604 | AMINOALKYLSTEROL COMPOUNDS WITH ANTITUMORAL AND NEUROPROTECTIVE ACTIVITY - Sterol derivatives of formula (I) and a method for the production of the compounds, a medicament using one of the compounds and a pharmaceutical composition comprising the medicament. | 11-10-2011 |
20120100124 | METHODS FOR DETERMINING THE ONCOGENIC CONDITION OF CELL, USES THEREOF, AND METHODS FOR TREATING CANCER - The invention relates to methods for detecting the oncogenic condition of cells, including step where the amount of the OCDO compound in said cells is measured, and to the uses thereof. The invention further relates to OCDO inhibitors for use in methods for treating cancer. | 04-26-2012 |
20140005156 | AMINOALKYLSTEROL COMPOUNDS WITH ANTITUMORAL AND NEUROPROTECTIVE ACTIVITY | 01-02-2014 |
20140221353 | Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer - The invention relates to methods for detecting the oncogenic condition of cells, including step where the amount of the OCDO compound in said cells is measured, and to the uses thereof. The invention further relates to OCDO inhibitors for use in methods for treating cancer. | 08-07-2014 |
Nathaniel Lombard Poirot, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20150279031 | IMAGING CONTROL TO FACILITATE TRACKING OBJECTS AND/OR PERFORM REAL-TIME INTERVENTION - A method includes acquiring image data from for a given time step. The image data represents at least one of an instrument and a target within an image space that includes patient anatomy. A given belief of system state is estimated to include an estimate of instrument state and target state determined from corresponding measurement and motion models computed based on the acquired image data and control input parameters for the given time step. An expected belief of system state is estimated for a subsequent time step based on the estimated given belief of system state and based on the measurement models and the motion models computed over a plurality of different control inputs parameters. An information metric is computed for each of the expected beliefs of system state and control input parameters are selected for the subsequent time step based on the computed information metrics. | 10-01-2015 |
Olivier Poirot, Paris FR
Patent application number | Description | Published |
---|---|---|
20100302911 | PORTABLE TELEPHONE PROVIDED WITH A MECHANICAL WATCH - Portable device, of all types, including a watch ( | 12-02-2010 |
Pascal Poirot, Bobigny Cedex FR
Patent application number | Description | Published |
---|---|---|
20090021953 | LIGHTING AND/OR INDICATING SYSTEM FOR A VEHICLE, WITH IMPROVED ACTUATOR CONTROL - The lighting and/or signaling system according to the invention comprises at least one lighting and/or signaling device which is able to emit at least one light beam and is equipped with at least one actuator for adjusting an angle of the light beam, and at least one actuator control device for controlling the actuator. According to the invention, the actuator control device transmits an active setpoint information item to the actuator only when a current value of the setpoint information item differs substantially from a previous value of the setpoint information item. The improved actuator control incorporated in the system according to the invention helps to achieve greater reliability and a longer service life. | 01-22-2009 |
Sandrine Poirot, L'Union FR
Patent application number | Description | Published |
---|---|---|
20140005156 | AMINOALKYLSTEROL COMPOUNDS WITH ANTITUMORAL AND NEUROPROTECTIVE ACTIVITY | 01-02-2014 |
Sandrine Poirot, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20140274984 | ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA-OL - The present invention relates to acid addition salts of 5α-hydroxy-6β-[2-(1H-imidazol-4-yl)ethylamino]cholestan-3β-ol, to their preparation and to applications thereof. | 09-18-2014 |
20140309417 | PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES - The present invention relates to a process for the preparation of sterol derivatives comprising the reaction of an α-epoxy compound with an amine in an alcohol comprising 3 to 5 carbon atoms as a solvent. | 10-16-2014 |
Sandrine Poirot, L' Union FR
Patent application number | Description | Published |
---|---|---|
20110275604 | AMINOALKYLSTEROL COMPOUNDS WITH ANTITUMORAL AND NEUROPROTECTIVE ACTIVITY - Sterol derivatives of formula (I) and a method for the production of the compounds, a medicament using one of the compounds and a pharmaceutical composition comprising the medicament. | 11-10-2011 |